Skip to main content
Contact Us
Subscribe
E-Edition
84°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcutis Biotherapeutics Inc
(NQ:
ARQT
)
10.07
-0.03 (-0.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcutis Biotherapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Arcutis Biotherapeutics Reveals Promising Data From Lead Drug In Pediatric Patients With Atopic Dermatitis
September 19, 2023
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) announced that the INTEGUMENT-PED Phase 3 trial of roflumilast cream 0.05%, in children ages 2 to 5 years with mild to moderate atopic dermatitis met its...
Via
Benzinga
Arcutis Announces Positive Results from INTEGUMENT-PED Pivotal Phase 3 Trial of Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
September 19, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis Submits Roflumilast Cream 0.15% Supplemental New Drug Application to the FDA for the Treatment of Atopic Dermatitis in Adults and Children Ages 6 Years and Older
September 12, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Why Shares of Arcutis Biotherapeutics Fell This Week
September 07, 2023
The company released phase 3 trial results for an atopic dermatitis cream.
Via
The Motley Fool
7 Analysts Have This to Say About Arcutis Biotherapeutics
August 10, 2023
Via
Benzinga
US Stocks Mostly Higher; RH Posts Upbeat Earnings
September 08, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 60 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 34,491.98 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Arcutis Announces Positive Long-Term Results of Roflumilast Cream 0.15% Showing Durable and Improved Efficacy Over Time and Favorable Safety Profile in Treatment of Mild to Moderate Atopic Dermatitis (AD)
September 07, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis to Present at Upcoming Investor Conference
September 05, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
8 Analysts Have This to Say About Arcutis Biotherapeutics
July 18, 2023
Via
Benzinga
Analyst Ratings for Arcutis Biotherapeutics
June 28, 2023
Via
Benzinga
Analyst Expectations for Arcutis Biotherapeutics's Future
June 12, 2023
Via
Benzinga
3 Biotech Stocks Due for a Massive Short Squeeze
August 31, 2023
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.
Via
InvestorPlace
Arcutis Biotherapeutics Publishes Annual Environmental, Social, and Governance (ESG) Report
August 31, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis Launches First Television Ad for ZORYVE® (Roflumilast) Cream 0.3%
August 29, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
August 21, 2023
Via
Benzinga
The Latest Analyst Ratings for Arcutis Biotherapeutics
May 17, 2023
Via
Benzinga
Arcutis Biotherapeutics: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Via
Benzinga
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
August 19, 2023
Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...
Via
Talk Markets
Arcutis Appoints Interim Chief Financial Officer (CFO)
August 18, 2023
Former and First Arcutis CFO, John Smither, Appointed Interim
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia
August 10, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis Announces Second Quarter 2023 Financial Results and Provides Business Update
August 08, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis to Report Second Quarter Financial Results
July 24, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Arcutis Announces ZORYVE® (Roflumilast) Cream 0.3% Has Been Included in a Preferred Position on National Formularies for CVS Caremark
July 17, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Shares of Arcutis Biotherapeutics Jumped This Week
June 09, 2023
The stock got a push when a British medical journal posted trials information on the company's lead product.
Via
The Motley Fool
Arcutis to Present at Upcoming Investor Conference
June 06, 2023
From
Arcutis Biotherapeutics, Inc.
Via
GlobeNewswire
7 Short-Interest Stocks to Target for Explosive Gains
May 18, 2023
For contrarian investors that can stand the heat, short-interest stocks to buy can offer significant rewards in a short time period.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.